University of California, Riverside News

news.ucr.edu is the official news website of the University of California, Riverside (UCR). The site features the latest news and events happening at UCR, as well as stories about UCR researchers and their discoveries. The site also has a section for popular stories and UCR in the news. One notable article covers a breakthrough in vaccines that could potentially end the need to chase strains, demonstrating the university's commitment to advancing public health.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

    New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

    Broke On: Monday, 15 April 2024 Scientists at the University of California and Georgia Tech have developed RNA-based vaccine strategies that target a common part of viral genomes, potentially offering broad protection against various strains including influenza and SARS-CoV-2. These vaccines are safer for vulnerable populations, as they don't rely on traditional immune responses or active proteins. Promising results in mice experiments indicate the need for further human testing.